These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28886178)

  • 1. Ethics approval in applications for open-access clinical trial data: An analysis of researcher statements to clinicalstudydatarequest.com.
    So D; Knoppers BM
    PLoS One; 2017; 12(9):e0184491. PubMed ID: 28886178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of available studies and dissemination of research using major clinical data sharing platforms.
    Vazquez E; Gouraud H; Naudet F; Gross CP; Krumholz HM; Ross JS; Wallach JD
    Clin Trials; 2021 Dec; 18(6):657-666. PubMed ID: 34407656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchers.
    Sudlow R; Branson J; Friede T; Morgan D; Whately-Smith C
    BMC Med Res Methodol; 2016 Jul; 16 Suppl 1(Suppl 1):73. PubMed ID: 27410386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices.
    Miller J; Ross JS; Wilenzick M; Mello MM
    BMJ; 2019 Jul; 366():l4217. PubMed ID: 31292127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial data sharing: here's the challenge.
    Kochhar S; Knoppers B; Gamble C; Chant A; Koplan J; Humphreys GS
    BMJ Open; 2019 Aug; 9(8):e032334. PubMed ID: 31439612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical trials by Ethics Committees in Germany: experience of applicants with the review of requests for opinion of the Ethics Committees - results of a survey among members of the German Association of Research-Based Pharmaceutical Companies (VFA).
    Russ H; Busta S; Riedel A; Zöllner G; Jost B
    Ger Med Sci; 2009 Jul; 7():Doc07. PubMed ID: 19675747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "You cannot collect data using your own resources and put It on open access": Perspectives from Africa about public health data-sharing.
    Anane-Sarpong E; Wangmo T; Ward CL; Sankoh O; Tanner M; Elger BS
    Dev World Bioeth; 2018 Dec; 18(4):394-405. PubMed ID: 28745008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Data transparency - an ethical imperative? Approaching the issues].
    Marckmann G; Strech D
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(3):207-13. PubMed ID: 21530911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data Access Committees.
    Cheah PY; Piasecki J
    BMC Med Ethics; 2020 Feb; 21(1):12. PubMed ID: 32013947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial transparency and orphan drug development: recent trends in data sharing by the pharmaceutical industry.
    So D; Joly Y; Knoppers BM
    Public Health Genomics; 2013; 16(6):322-35. PubMed ID: 24503593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fostering EMA's transparency policy.
    Banzi R; Bertele' V; Demotes-Mainard J; Garattini S; Gluud C; Kubiak C; Ohmann C
    Eur J Intern Med; 2014 Oct; 25(8):681-4. PubMed ID: 25200801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study.
    Morrow RL; Mintzes B; Gray G; Law MR; Garrison S; Dormuth CR
    Clin Ther; 2022 Mar; 44(3):374-388. PubMed ID: 34955232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainties about the need for ethics approval in Switzerland: a mixed-methods study.
    Gloy V; McLennan S; Rinderknecht M; Ley B; Meier B; Driessen S; Gervasoni P; Hirschel B; Benkert P; Gilles I; von Elm E; Briel M
    Swiss Med Wkly; 2020 Aug; 150():w20318. PubMed ID: 32799307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks?
    Evans NG; Hills K; Levine AC
    AMA J Ethics; 2020 Jan; 22(1):E28-35. PubMed ID: 31958388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstacles to researching the researchers: a case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trials.
    McKenzie JE; Herbison GP; Roth P; Paul C
    Trials; 2010 Mar; 11():28. PubMed ID: 20302671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncommercial US Funders' Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability.
    Whitlock EP; Dunham KM; DiGioia K; Lazowick E; Gleason TC; Atkins D
    JAMA Netw Open; 2019 Jan; 2(1):e187498. PubMed ID: 30681715
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.